首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical development and technology

缩写:PHARM DEV TECHNOL

ISSN:1083-7450

e-ISSN:1097-9867

IF/分区:2.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1903
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xuemei Gu,Jie Wang,Jing Chen et al. Xuemei Gu et al.
The natural flavonoids quercetin (Que) and kaempferol (Kae) show great potential for anti-aging applications but suffer from poor solubility and skin permeability. This study aimed to develop a synergistic topical emulsion system to overcom...
Yousef A Bin Jardan,Mustafa R Abdulbaq,Sahar A M Omran et al. Yousef A Bin Jardan et al.
Diabetic wounds need effective and prompt treatment otherwise, it will be complicated with sever bacterial infections. In this study, hydrogels containing Lepidium sativum seeds aqueous extract (LSae), metformin (MET) and combination (LSae ...
Omobolanle A Omoteso,Handsome Ndlovu,Sandile M Khamanga et al. Omobolanle A Omoteso et al.
Patient rejection of unpalatable products can adversely affect therapeutic adherence, potentially leading to treatment failure. Taste masking is a goal in pharmaceutical development, particularly when developing formulations for paediatric ...
Beatriz N Guedes,João G De Oliveira Neto,Aleksandra Zielińska et al. Beatriz N Guedes et al.
A new delivery system for the dual loading of resveratrol and rutin (RES-RU-micelles), is described and characterized. Analyzes were carried out to determine the size parameters (mean particle size and polydispersity index) and surface elec...
Hafsa P V,Nithya Haridas,Vidya Viswanad Hafsa P V
Neutrophillic asthma, characterized by persistent airway inflammation and poor corticosteroid responsiveness, presents a significant therapeutic challenge. Repurposing rapamycin, an mTOR inhibitor, and simvastatin, a statin with anti-inflam...
Rahul Jha,Arzoo Sekhani,Nikita Panchal et al. Rahul Jha et al.
Nilotinib (NH), a second-generation tyrosine kinase inhibitor for chronic myelogenous leukemia (CML), exhibits poor aqueous solubility and low intestinal permeability, classifying it as a Biopharmaceutics Classification System (BCS) Class I...
Akash V Narawade,Manoj B Shinde,Varsha B Mane et al. Akash V Narawade et al.
Rosuvastatin is a BCS class II drug effective in the management of atherosclerosis. To enhance solubility and efficacy, Rosuvastatin-β-Cyclodextrin complex-loaded chitosan nanoparticles (R-CD-CNs) were developed. β-cyclodextrin was crossl...
Balisa Mosisa Ejeta,Malay K Das,Sanjoy Das et al. Balisa Mosisa Ejeta et al.
Harnessing the immune system, vaccines function as both prophylactic shields and precision-guided therapeutic agents, offering a promising strategy of a dual-armament approach in the fight against cancer. Previous landmark advances include ...
Abhay Thakur,Rohit Sharma,Rahul Sharma et al. Abhay Thakur et al.
Nanozymes are engineered nanoparticles that mimic enzyme-like catalytic activities and have gained significant attention in bioanalytical and biomedical applications. A broad range of nanomaterials has been explored for their intrinsic cata...
Areej Eskandrani,Sara H Akl,Yahya H Shahin et al. Areej Eskandrani et al.
Berberine (BBR) exhibits broad antimicrobial and metabolic activities but suffers from limited bioavailability. Nanostructured lipid carriers (NLCs) can enhance oral delivery, while selenium (Se) coating may synergistically improve hypoglyc...